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Abstract
Background: This study was designed to investigate the invasion of human papillomavirus (HPV) positive human
cervical carcinoma cell lines in human leiomyoma-based extracellular matrices in vitro, and to test the suitability of
the model for studying the irradiation effects on the cancer cell invasion.
Methods: HPV positive cervical carcinoma cell lines SiHa and CaSki, and HPV negative squamous cell carcinoma cell
line HSC-3 were used. CaSki cells contain around 600 copies of HPV 16 virus in the genome, whereas SiHa have
only 1–2 copies per cell. Cells were analyzed using two different human tumor derived extracellular matrix methods
(3D myoma disc model, and Myogel Transwell invasion assay). Cultures were irradiated with 4 Gy. Myoma invasion
area and the depth of invasion were measured with ImageJ 1.51j8 software. Statistical analyses were performed
with SPSS Statistics (IBM SPSS® Statistics 25).
Results: All cells invaded through Myogel coated Transwell membranes and within myoma discs. In myoma discs,
a difference in the invasion depth (p = 0.0001) but not in invasion area (p = 0.310) between the HPV positive cell
lines was seen, since SiHa (less HPV) invaded slightly better than CaSki (more HPV). HSC-3 cells (HPV negative)
invaded deepest (p = 0.048) than either of the HPV positive cell line cells. No difference was detected in the
invasion area (p = 0.892) between HPV positive and HPV negative cells. The ionized radiation significantly reduced
the invasion depth of HSC-3 (p = 0.008), SiHa (p = 0.0001) and CaSki (p = 0.005). No significant effect on the invasion
area was detected in any of the cell lines. However, a significant difference was observed between SiHa and CaSki
in the reduction of the invasion depth after radiation (p = 0.013) as the reduction was greater with SiHa than CaSki.
Conclusions: Both solid and gelatinous human leiomyoma-based extracellular matrix models were suitable
platforms to study the invasion of HPV positive cervical carcinoma cells in vitro. SiHa cells with less HPV copy
number cells invaded slightly better and were slightly more sensitive to irradiation than CaSki cells with high HPV
copy number. However, there was no drastic differences between the invasion properties of these carcinoma cells.
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Background
In vitro models are important tools for cancer research.
For cell cultures, the most commonly used matrix over
the past decades has been Matrigel® (BD Matrigel
Matrix, BD Biosciences, New Jersey, United States)
which is derived from mouse sarcoma [1]. However, in
order to better understand human cancer cells inter-
action with human tumor matrices there has been a
need for human tumor tissue-derived matrices. Recently,
a 3D solid in vitro human uterus leiomyoma tissue de-
rived disc model has been developed for invasion ana-
lyses followed by a gelatinous Myogel matrix for
attachment, Transwell and spheroid invasion assays [1–
6]. Myoma discs offer all the main parts of tumor micro-
environment; such as vessels, collagen fibers and soluble
factors, including cytokines and growth factors [4, 7–
10]. This provides us with better knowledge of cancer
cells behavior in vivo. HSC-3 is an aggressively invading
HPV negative squamous cell carcinoma cell line which
has been extensively studied in both myoma discs and
Myogel assays [2, 8, 11–15].
Persistent infection with high-risk (HR) human papil-
lomavirus (HPV), mainly with HPV 16, is a major cause
of cervical squamous cell carcinomas (CSCC) and in-
creasingly also oropharyngeal carcinoma [16]. SiHa and
CaSki are two HPV 16 positive commercially available
carcinoma cell lines derived from human squamous cell
carcinomas of cervical uteri. CaSki cells contain approxi-
mately 600 viral copies per cell, whereas SiHa has less
than ten copies per cell [17, 18]. CaSki also contains
some sequences related to HPV 18 [19]. Cervical carcin-
oma cell lines have not previously been investigated in
human tumor-based extracellular matrices in vitro.
Irradiation treatment may be beneficial or harmful for
the cancer patient. HPV positive carcinomas are shown
to be more radiosensitive than HPV negative carcinomas
and the patients have a better prognosis and treatment
outcome [20–26]. The HPV negative CSCCs have also
been shown to have greater potential to metastasize
(with aggressive p53 mutations), which would explain
the worse prognosis and poorer growth control without
radiation treatment [26–28]. Based on this controversy,
we wanted to investigate if the in vitro human myoma
tissue-based extracellular matrix models are suitable for
testing the radiation impact on the HPV positive carcin-
oma cells. HPV negative cells was used as a positive con-
trol in this study.
Methods
Cell lines
Two HPV positive squamous cell carcinoma lines SiHa
(ATCC® HTB-35™) (LGC Standards GmbH, Wesel,
Germany) and CaSki (ATCC® CRL-1550™) (LGC Stan-
dards GmbH, Wesel, Germany) were used for cell
cultures. SiHa and CaSki are HPV 16 positive carcinoma
cell lines. CaSki cells contain approximately 600 viral cop-
ies of HPV 16 per cell and SiHa less than ten copies per
cell [17, 18]. As a positive control, a HPV negative human
oral squamous cell carcinoma cell line HSC-3 (JCRB 0623;
Osaka National Institute of Health Sciences, Osaka, Japan)
with known aggressive behavior was used [2, 8, 11–15].
The SiHa and CaSki were cultivated in DMEM with
10% heat-inactivated fetal bovine serum (FBS), 100 U/ml
penicillin, 100 μl/ml streptomycin and 1% non-essential
amino acids (all from Gibco, Life Technologies, Paisley,
UK). HSC-3 cells had a different media, which consisted
of DMEM/F-12 (Dulbecco’s modified Eagle’s media/F12,
1:1) with 10% heat-inactivated fetal bovine serum (FBS),
100 U/ml penicillin, 100 μl/ml streptomycin (Gibco, Life
Technologies, Paisley, UK) in addition with 4 mg/ml
Hydrocortisone, 50 μg/ml Ascorbic Acid (vitamin C) and
250 ng/ml Fungizone (Sigma-Aldrich, Ayrshire, UK).
Human extracellular matrix models
The human uterine leiomyoma–based solid matrix
model, the myoma disc model, has been previously de-
scribed in detail in Nurmenniemi et al. [4]. Briefly, the
myomas have been obtained from routine surgical pro-
cedures after obtaining the patients’ informed consent.
The original study was approved by the Ethics Commit-
tee of the Oulu University Hospital (statement #8/2006,
amendment 19/10/2006 and statement #35/2014,
28.4.2014). The myoma discs were cut from 3mm slices
with 8 mm biopsy punch and placed in − 70 °C in cell
culture media with 10% DMSO (Sigma-Aldrich) for stor-
age prior to be used in invasion experiments.
The gelatinous leiomyoma matrix, Myogel, has been
prepared as described earlier [3]. Briefly, the protocol is
similar to the Matrigel® preparation with slight modifica-
tions [29]. The liquid nitrogen frozen myoma tissue
from several patients were combined, grounded to pow-
der, suspended to NaCl buffer, homogenized, and the
protein concentration was matched to that of Matrigel®.
Myogel preparations were stored in − 20 °C.
Cell viability testing
Cell viability tests were performed to all cell lines cul-
tured either on top of the Myogel or on top of plastic
wells. For Myogel assay, the 96-well Transwell plate was
coated with 50 μl Myogel (0.5 mg/ml) and left to settle
overnight in the cell culture incubator. The excess of the
coating was removed carefully with suction, and 1000
cells in 100 μl media per well were added. The cells were
allowed to grow for 72 h at + 37 °C. CellTiter-Glo®
(CTG) 2.0 Luminescent Cell Viability Assay (Promega,
Madison, WI, USA) was used to determine the cells via-
bility. The plate was taken out from the incubator to
room temperature for 30 min before starting the assay.
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One hundred microliters of CellTiter-Glo was dispensed
in each well. The plate was put on a plate shaker (Hei-
dolph, Schwabach, Germany) for 5 min at 450 rpm and
then in plate spinner (Thermo Scientific, Massachusetts,
USA) for 5 min at 1000 rpm. The plate was then placed
in the BMG PHERAstar FS (BMG Labtech, Offenburg,
Germany) plate reader to detect cell viability. The results
represent an average of three independent experiments.
Myogel Transwell invasion assay
For the Myogel Transwell invasion assay, a mix of Myo-
gel with 0.8 mg/ml rat collagen and 2.4 mg/ml Myogel
was prepared. A 50 μl of this Myogel mix was used to
coat 24-well Transwell plate, followed by 30min to 1 h
incubation at + 37 °C for the gel to develop. A volume of
500 μl of normal cell culture media was added to the
bottom of the well. Total of 70,000 cells in 200 μl lactal-
bumin media were added on top of Myogel. In lactalbu-
min media, the FBS was replaced by 0.5% lactalbumin
(Sigma-Aldrich).
The cells were allowed to grow and invade for 72 h
and then fixated with 4% formaldehyde for 1 h and
washed with PBS. Invaded cells were stained with 1%
Toluidine blue + 1% Borax at room temperature. After
staining, the cells were washed several times with dis-
tilled water and non-invaded cell from the upper cham-
ber were carefully removed with wet cotton swabs.
Staining was eluted with 1% Sodium Dodecyl Sulfate
(SDS) and transferred to 96-well plate. The absorbance
was measured at 650 nm with Synergy™ HT (BioTek In-
struments, Inc., Winooski, Vermont, USA) according to
manufacturer’s instructions. The results represent an
average of three cultures, performed in triplicate.
Myoma invasion assay and irradiation
To prepare the cultures, the myomas were thawed to
room temperature and washed with appropriate media.
Myoma discs were placed in tubes with 10ml media to
wash overnight. After 24 h, myomas were placed in a 24-
well Transwell inserts (diameter, 6.5 mm; Corning, Inc.,
Corning, NY). Around 750,000 SiHa or CaSki or HSC-3
cells in 50 μl media were added on top of each myoma
disc. Lower chamber of the well was filled with 0.5ml cell
culture media. Cells were allowed to attach and grow for
24 h in + 37 °C. After this, the myoma discs were removed
from the inserts and placed in 12-well Transwell on top of
metal grid and a nylon membrane with 1ml media in the
bottom of the well. The cells were allowed to invade for
13 days. The cell culture media was changed in every 3 to
4 days. The cultures were finished on day 14, and the
tissues were prepared for histology.
Faxitron MultiRad350 (DatekMedíco, Aarhus, Denmark)
irradiator was used according to manufacturer’s instruc-
tions for a part of the myomas (one 12-well plate) in order
to give the cells ionized radiation equivalent to 4 Gy on the
third day of cultivation. One 12-well plate Transwell with
the cells was similarly carried around and mock-irradiated
simultaneously.
Hematoxylin-eosin (HE) staining was used to esti-
mate the overall success of the cell culture experi-
ment, and cytokeratin staining (Cytokeratin High
Molecular Weight, Clone 34BE12, Dako, Clostrup,
Denmark) was used to analyze the invasion depth and
invasion area of the cells (see below). All experiments
were performed in triplicates, representing an average
of two to six independent cultures.
Cell invasion analyses
Fiji ImageJ 1.52a (National Institute of Health, USA)
software was used to analyze and calculate the invasion
depth and the invasion area of the myoma invasion
model cultured with SiHa, CaSki or HSC-3 cells, as de-
scribed in detail in Åström and co-workers [5]. The in-
vasion index (%) depicts a proportion of an area where
cells have invaded in percentage and is calculated as epi-
thelium area divided by the total area of invaded cells
area. The invasion area describes the overall area (μm2)
of invaded cells. The average of invasion depth (μm) de-
picts how deep the cells have been able to invade into
the tissue.
The statistical analyses of all the results were per-
formed with SPSS Statistics (IBM SPSS Statistics version
21). After the normality testing of the data, for unrelated
samples, either the independent samples Student’s T-test
or Mann-Whitney’s U-test were used to determine stat-
istical differences. If the samples were related, either
paired samples t-test or Wilcoxon signed-rank test were
used. In all calculations, a value of p < 0.05 was consid-
ered statistically significant.
Results
Cell viability assay
All three cell lines survived in Myogel extract coated
wells (Fig. 1). SiHa cells showed significantly higher via-
bility when cultured on Myogel coated wells compared
with plastic (p = 0.0001). No differences were observed
in the viability of either CaSki or HSC-3 when compared
controls to Myogel.
Myogel Transwell invasion assay
In the Myogel Transwell invasion assay (Fig. 2), all
the cell lines invaded through the Myogel mixture.
We detected no statistically significant differences in
the results according to the different cell lines (HSC-
3 and SiHa p = 0.406, HSC-3 and CaSki p = 0.406,
SiHa and CaSki p = 0.963).
Tuominen et al. Virology Journal           (2020) 17:87 Page 3 of 9
Myoma invasion assay
All three cell lines invaded within myoma discs (Fig. 3a).
In the invasion depth, SiHa and CaSki had a statistically
significant difference (p = 0.0001). The difference in the
invasion depth was also significant between HSC-3 and
CaSki (p = 0.003), but not between SiHa and HSC-3 (p =
0.602). HPV negative HSC-3 invaded slightly better than
HPV positive (SiHa and CaSki) cells combined (p =
0.048). The invasion depth of all three cell lines are pre-
sented in Fig. 3b.
Considering invasion area (Fig. 3c), no significant
differences were detected between the cell lines
(HSC-3 and SiHa p = 0.937, HSC-3 and CaSki p =
0.699 and SiHa and CaSki p = 0.310). No differences
were neither observed in invasion area based on the
HPV status (p = 0.892).
The invasion index with HSC-3 reached up to 53.6%.
SiHa and CaSki presented more modest invasion index
of 21.3 and 30.0%. These differences did not reach statis-
tical significance.
Fig. 1 Cell viability. SiHa cells on Myogel presented better viability when compared to the control. Other cell lines did not have differences
between Myogel and control. ***p < 0.001
Fig. 2 Myogel Transwell invasion assay. The absorbance values for Myogel Transwell invasion were 0.32 for HSC-3, 0.31 for SiHa and 0.25 for
CaSki. No statistically significant differences (p < 0.05) were observed in Myogel Transwell invasion between the different cell lines
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Irradiation effect to cell invasion
After a single 4 Gy irradiation, the invasion depth was
significantly reduced in irradiated HSC-3 (from 1.25 μm
to 0.66 μm, p = 0.008, Fig. 4a), SiHa (from 1.28 μm to
0.42 μm, p = 0.0001, Fig. 4b) and CaSki (from 0.91 μm to
0.50 μm, p = 0.005, Fig. 4c) cell myoma tissue sections
when compared to the mock-radiated myoma sections
(Fig. 4d). Between the two HPV positive cell lines, the
invasion decreased significantly more in SiHa than in
CaSki cells (p = 0.013).
Fig. 3 Myoma invasion assay. The Cytokeratin stained figures of HSC-3, SiHa and CaSki (a) are presented at 50 x magnification. Arrows have been
added in SiHa to represent the small invaded islet (“buds”), also the area shown has been enlarged below to clearly depict the invasion. The
invasion depth (b), was 1.25 μm in HSC-3, 1.28 μm in SiHa and 0.91 μm in CaSki. The difference between SiHa and CaSki was statistically
significant (p < 0.01) in the invasion depth without irradiation. The invasion area (c) had also some differences. The invasion area in HSC-3 was
86.2 mm2, 94.3 mm2 in SiHa and 74.9 mm2 in CaSki. Significant differences were observed between HSC-3 and CaSki (p < 0.05) and SiHa and CaSki
(p < 0.05). The statistically significant differences have been marked in the figures by adding the asterisks (*p ≤ 0.001)
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No statistically significant difference was observed in the
reduction of invasion area after radiation in HSC-3 (from
86.2mm2 to 32.1mm2, p = 0.109), in SiHa (from 94.3
mm2 to 5.61mm2, p = 0.109) or in CaSki (from 74.9mm2
to 3.90mm2, p = 0.109) despite the major differences in
the invasion depth after irradiation (Fig. 4e). No differ-
ences were neither observed between the HPV positive
cervical carcinoma cell lines in the reduction of invasion
area (p = 0.222).
The calculated invasion indexes decreased significantly
in all cell lines (HSC-3 53.6% without irradiation and
29.5% after (p = 0.003); SiHa 21.3% without irradiation
and 13.7% after (p = 0.003) and CaSki 30.0% without ir-
radiation and 26.5% after (p = 0.006)) as demonstrated in
the statistically significant differences in the invasion
depths as well.
Discussion
Human extracellular matrices, myoma discs and Myogel,
presented as useful study platforms for cervical carcin-
oma cell lines invasion, since both SiHa and CaSki cells
invaded these matrices and 4 Gy irradiation significantly
reduced their invasion in myoma disc experiment.
We have introduced gelatinous Myogel Transwell in-
vasion assay, which has proved to be a fast method for
cancer cells invasion experiments [1, 3, 6, 7, 30]. Carcin-
oma cells invade faster in Myogel than in the tradition-
ally used commercial Matrigel® [4, 6]. Viability was good
in all of the cell lines. Nevertheless, SiHa with Myogel
performed significantly better than without Myogel (p =
0.0001). Similar differences were not observed with
CaSki or HSC-3. Furthermore, in our Myogel Transwell
invasion assay there were no differences between cell
lines in the invasion through the Myogel mixture; inva-
sion was detected similarly in both of the HPV positive
cervical carcinoma cell lines.
The myoma disc model closely mimics the human
tumor microenvironment of solid cancers [1, 2, 8, 9].
Here we detected major differences between SiHa (less
HPV) and CaSki (more HPV) in the invasion depths, as
SiHa invaded deeper and more aggressively. They are
both cervical squamous cell carcinoma cell lines, but each
neoplasia is individual. We cannot rule out the possibility
of differences between the cell lines themselves. However,
this may also reflect to the difference between the viral
copy numbers with the carcinoma cells. Nonetheless, the
difference was not observed in the invasion area. This
may, at least partly, be explained by the different invasion
patterns on cellular level. SiHa cells invaded either as sin-
gle cells or with small islands (buds) deeper into the my-
oma tissue while CaSki formed bigger invasive cell
droplets and invaded less deep than SiHa cells (Fig. 3a).
The carcinoma cell invasion budding, as detected in
SiHa invasion to myoma, have independently been con-
nected in clinical studies with deeper invasion depth,
venous invasion, lymph node metastasis and poor prog-
nosis in head-and-neck squamous cell carcinoma
(HNSCC) and colorectal cancer [31–40]. Also, both in
Fig. 4 Irradiation effect to cell invasion. Cytokeratin stained sections at
× 50 magnification before (0 Gy) and after (4 Gy) irradiation in the HSC-
3 (a), SiHa (b) and CaSki (c) are presented. After irradiation the invasion
depth decreased from 1.25 μm to 0.66 μm in HSC-3 (p < 0.001), from
1.28 μm to 0.42 μm in SiHa (p < 0.001) and from 0.91 μm to 0.50 μm in
CaSki (p < 0.01). Also, the invasion area was decreases in HSC-3 from
86.2mm2 to 32.1 mm2, SiHa from 94.3mm2 to 56.1 mm2 and CaSki
from 74.9mm2 to 39.0mm2, but not with statistical significance. The
differences in invasion depth (f) and invasion area (g) were measured
and compared before (0 Gy) and after (4 Gy) irradiation. Statistically
significant differences have been marked to figures as *p≤ 0.001
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cervical adenocarcinomas and CSCCs, tumor budding
has been associated with higher histological tumor
grade, invasive pattern, lymph node metastasis, bigger
tumor size and poorer prognosis [41, 42]. Jesinghaus and
collagues [42] have suggested in their study, that tumor
budding could be used as an individual prognostic factor
in CSCCs. There have not been similar studies concern-
ing HPV positive carcinomas in either HNSCCs or
CSCCs, but we would speculate that similar effect might
be seen regardless of the HPV status, as was observed
with HPV positive SiHa cell in our study.
Since significant differences were observed in myoma
discs between different cell lines, we further wanted to
investigate the impact of ionized radiation to cell inva-
sion. We have shown in the previous myoma experi-
ments that 4 Gy radiation is optimal dose to for the
major changes in various oral carcinoma cell lines inva-
sion [30]. Here we detected that the invasion depth was
significantly reduced in all experiments with dose of 4
Gy, which was in line with our previous experiment [30].
We also showed that ionized radiation affected to the
total invasion area, and the invasion index decreased
clearly in all of the cells studied: 27.1% in HSC-3, 7.6%
in SiHa, and 3.5% in CaSki cells. These results suggest,
that ionized radiation reduces, not only the invaded cells
invasion depth into the tissue, but also the overall vol-
ume of the invaded cell islets, decreasing the aggressive
potential of all the carcinoma cells. These findings sug-
gest that even a relatively small radiation dose impacts
to the cell invasion.
Between HPV positive cervical cell lines, a difference
was observed regarding the reduction of invasion after
irradiation, as SiHa with less HPV, the reduction was
greater than with CaSki. HPV positive CSCC and
HNSCC are known to have more favorable prognosis
and treatment outcome than HPV negative [23, 26, 43].
HPV negative and HPV positive CSCC patients with
multiple simultaneous infections have been observed to
have poorer prognosis even after radiation treatment
[24, 25]. No difference to radiation between HPV posi-
tive and HPV negative cell lines in HNSCCs have been
observed [44, 45], but still one study have presented
higher radiosensitivity of HPV positive HNSCC cells
[46]. Based on our study, HPV copy number had only a
modest effect on the radiosensitivity of the cell invasion.
However, the trend was that the radiation was more ef-
fective towards non (HSC-3) and less HPV infected
(SiHa) carcinoma cells than in case of high copy number
of HR-HPV 16 (CaSki).
Our study has some limitations. Although the myoma
discs provides an excellent hypoxic, human tumor de-
rived 3D solid platform to study cancer cells behavior
in vitro, it is essential to keep in mind that human body
has several other factors, such as blood derived cells and
cytokines that affect cancer cells aggressiveness in vivo.
As a technique, the use of Myogel Transwell invasion
assay is quite sensitive and multiple repetitions are
needed in order to produce secured results. Further-
more, we only used three different cell lines, two HPV
positive and only one HPV negative, and here we
present novel results on the HPV positive cells behavior
in myoma and Myogel assays. The differences could be
explained by individual nature of each cell line. SiHa and
CaSki cell lines are HPV 16 positive cervical cancer cell
lines but have different origins and CaSki even might
contain some sequences of HPV 18 [17–19]. The results
presented here shows how these cell lines interact with
myoma and Myogel and that the cell invasion is evident
in all three different cases. We have used oral squamous
cell carcinoma cell line HSC-3 as a control in our exper-
iments, since it has most widely been used in Myoma
and Myogel studies previously [2, 8, 11–15]. Therefore,
we already have a good knowledge of its behavior in
these cell matrices and it offers us the best way to com-
pare between the different cell lines. Furthermore, simi-
lar outcomes were observed between different cell lines
in different experiments.
Conclusions
Solid and gelatinous human uterine leiomyoma-based
extracellular matrix models were usable platforms to
study the invasion of HPV positive cervical carcinoma
cells in vitro. Carcinoma cells with less HPV copy num-
ber (SiHa) invaded slightly better and were slightly more
sensitive to irradiation than cells with a high copy num-
ber (CaSki).
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